Bridget Moore is an associate in Sterne Kessler’s Trial & Appellate Practice Group. Bridget focuses her practice on patent litigation, including biotech and pharmaceutical technologies, and cases arising under the Hatch-Waxman Act.

Bridget graduated from Cornell Law School, where she was a general editor of the Cornell Journal of Law and Public Policy and a member of the Women’s Law Coalition. While attending law school, Bridget led efforts to obtain and evaluate scientific evidence establishing factual innocence within Cornell’s Capital Punishment Clinic. Additionally, Bridget volunteered with the Tenants Advocacy Program to provide free legal assistance to residential tenants in upstate New York.

Bridget received her B.S. in biopsychology, cognition, and neuroscience from the University of Michigan where she graduated with High Distinction.

In her free time, Bridget enjoys nature walks, growing balcony vegetables, and attempting to cultivate carnivorous plants.

  • J.D., Cornell University
  • B.S., Biopsychology, Cognition, and Neuroscience, University of Michigan, High Distinction

  • District of Columbia

Related News & Insights

From Bridget Moore

Articles

April 9, 2026

Key Provisions of the Remedy Act and Their Impact on Hatch‑Waxman Litigation

Sterne, Kessler, Goldstein & Fox Multiple Authors

Reports

February 20, 2026

2025 Federal Circuit IP Appeals: Summaries of Key 2025 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Client Alert

September 29, 2025

IP Hot Topic: “Confusing and Unclear” Expert Testimony Results in Loss of $166.3 Million Jury Verdict

William H. Milliken, Bridget Moore